New brain scan study aims to sharpen epilepsy surgery
NCT ID NCT02107989
First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 17 times
Summary
This study uses advanced brain scans (MRI and MEG) to better locate seizure-causing areas in people with epilepsy who are considering surgery. Researchers will also create a database of normal brain images from healthy volunteers. The goal is to improve surgical outcomes by comparing imaging methods.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could improve how doctors locate seizure-causing brain areas, leading to more precise epilepsy surgeries.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly benefit participants, and results may not change current practices.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 700 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2014
- Expected to finish
-
Mar 2028
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
500 adults and children (age 8 and up) with uncontrolled focal epilepsy, and 200 age-stratified healthy volunteers.
- Ages
-
8 to 120 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA FOR PATIENTS: * Age 8 and older * Evaluated or under evaluation for epilepsy surgery under protocol 18-N-0066,11-N-0051 or 16-N-0041 * Documentation of focal epilepsy based on MRI, EEG and/or ictal semiology * Ability to give informed consent, have or be able to assign a legally authorized representative able to give consent (for adults without consent capacity), or parent/guardian able to provide informed consent (for a child). INCLUSION CRITERIA FOR PATIENTS SOLELY CONTRIBUTING DATA: * Had epilepsy surgery with presurgical evaluation under 18-N-0066 * Age 8 and up at the time of epilepsy surgery evaluation * Had a preoperative structural brain MRI of the type used in this protocol INCLUSION CRITERIA FOR HEALTHY VOLUNTEERS: * Age 8 and older * Ability to give informed consent or have a parent/guardian able to provide informed consent if a child. * Ability to cooperate with MRI scanning without anesthesia EXCLUSION CRITERIA FOR PATIENTS: * Contraindications to MRI or MEG studies (such as pacemakers, cochlear implants, shrapnel, permanent eyeliner) * Claustrophobia or anxiety disorders exacerbated by the MRI scanner * Pregnancy. All females of childbearing potential must have a negative pregnancy test prior to MRI scanning EXCLUSION CRITERIA FOR PATIENTS SOLELY CONTRIBUTING DATA: -Not able or willing to give consent or do not have an appropriate surrogate who can provide consent EXCLUSION CRITERIA FOR HEALTHY VOLUNTEERS: * Contraindications to MRI or MEG studies (such as pacemakers, cochlear implants, shrapnel, permanent eyeliner) * Claustrophobia or anxiety disorders exacerbated by the MRI scanner * Significant medical conditions that may affect the central nervous system, such as psychiatric disorders (such as mood disorders, psychotic disorders, substance abuse or dependence), significant neurologic disorders (such as brain injury, neurodegenerative disorders, multiple sclerosis, stroke, movement disorders, epilepsy), or active systemic disease that may affect the central nervous system (such as uncontrolled hypertension, autoimmune disorders or other inflammatory disorders, neoplastic disease) * Use of centrally acting medications in the past 6 weeks, such as benzodiazepines, barbiturates, antidepressants, beta-blockers, and drugs for treating epilepsy or migraine * Pregnancy. All females of childbearing potential must have a negative pregnancy test prior to MRI scanning
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Epilepsy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can lavender and lullabies help kids with epilepsy sleep better?
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can a Comfort-Focused education program improve life with epilepsy?
- Can video games rewire young brains after injury?
- High-Fat Diet's effect on epilepsy: scientists track brain signals
- Brain implant that fires at seizures tested in teens